Pearl Steinzor

Remission is now defined as 0% BSA or IGA 0 for ≥6 months on treatment, per a Delphi consensus led by the National Psoriasis Foundation.

New research reveals that early discontinuation of adjuvant immunotherapy for melanoma does not lead to worse outcomes.

A recent study reveals that women with psoriasis are more likely to discontinue biologic treatments, including IL-17 and IL-23 inhibitors, due to adverse events and treatment dissatisfaction.

A study reveals that biologics targeting IL-12, IL-23, and IL-17 lower the risk of serious infections in older adults with psoriatic disease.

Higher stress hyperglycemia ratios are linked to elevated mortality risk in psoriasis, highlighting its systemic nature and need for intensive care.

The oral TYK2 inhibitor demonstrated biologic-level efficacy.

Weekend treatment with cyclosporine may be beneficial for patients with moderate to severe psoriasis, according to a new study.

This research indicates that psychological well-being serves a key role in the management of psoriatic disease.

A recent review and meta-analysis says this statistic may be due in part to nocebo effects.

Two posters at the AAD Annual Meeting examined disparities in skin cancer survival between urban and rural areas and assessed how having skin of color affects this.

The topical therapy was more effective in patients with psoriasis and AD when compared to a vehicle control cream.

Most studies involving the treatment of psoriasis do not contain any images of patients, a review finds.

Label warnings may affect the initiation of new treatment and real-world switching patterns for psoriasis patients starting treatment with risankizumab.

In addition to improvements in work productivity, tildrakizumab also demonstrated significant efficacy and safety.

Investigators noted that patients with mild psoriasis experience a less favorable status when compared to patients with moderate psoriasis.

Black and male patients exhibited a higher prevalence of palmoplantar psoriasis when compared with White patients.

Researchers explored the relationship between psoriasis severity and its link to coronary microvascular dysfunction in the largest such study to date.

Researchers noted a lack of significant differences in access to biologics among different populations.